ADVM-022-07
Showing 26 - 50 of 1,568
Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in
Recruiting
- Adult Primary Liver Cancer
- +2 more
- TSR-022 and TSR-042
-
Honolulu, HawaiiUniversity of Hawaii
Sep 22, 2021
Migraine Disorders Trial (Rizatriptan 5 mg, Rizatriptan 10 mg, Standard Care)
Completed
- Migraine Disorders
- Rizatriptan 5 mg
- +2 more
- (no location specified)
Feb 1, 2022
Migraine Headache Trial (rizatriptan benzoate (MK0462), Comparator: )
Completed
- Migraine Headache
- rizatriptan benzoate (MK0462)
- Comparator: placebo
- (no location specified)
Feb 1, 2022
Sickle Cell Disease Trial (open-label GBT021601)
Not yet recruiting
- Sickle Cell Disease
- open-label GBT021601
- (no location specified)
Nov 21, 2022
Retrospective Study of COVID-19 on Reproductive Function
Recruiting
- COVID-19
- no intervention
-
Nanjing, Jiangsu, China
- +2 more
Jan 28, 2023
Extracorporal Membrane Oxygenation for Critically Ill COVID-19
Active, not recruiting
- COVID-19
- ECMO
-
Hasselt, Limburg, BelgiumJessa Hospital
Dec 14, 2021
Gestational Diabetes Trial in Rawalpindi (Placebo supplementation, Vitamin D supplementation)
Not yet recruiting
- Gestational Diabetes Mellitus
- Placebo supplementation
- Vitamin D supplementation
-
Rawalpindi, Punjab, PakistanPakistan Railway Hospital
Nov 17, 2023
PCNSL, Secondary CNS Lymphoma Trial in Beijing, Guangzhou, Shanghai (ICP-022)
Recruiting
- PCNSL
- Secondary Central Nervous System Lymphoma
-
Beijing, Beijing, China
- +4 more
Jul 28, 2021
Part 1:r/r B-cell Malignancies, Part 2:B-cell Malignancies Trial in United States (Orelabrutinib (ICP-022))
Recruiting
- Part 1:r/r B-cell Malignancies
- Part 2:B-cell Malignancies
- Orelabrutinib (ICP-022)
-
Phoenix, Arizona
- +26 more
Dec 7, 2021
Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)
Completed
- Tuberculosis, Multidrug-Resistant
-
Beijing, China
- +7 more
Sep 30, 2021
Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)
Terminated
- Acute Myeloid Leukemia
- Myeloid Dysplastic Syndrome
-
Buffalo, New York
- +20 more
Jan 21, 2022
Pigmented Villonodular Synovitis, TGCT, Tenosynovial Giant Cell Tumor Trial (AMB-05X)
Not yet recruiting
- Pigmented Villonodular Synovitis
- +2 more
- AMB-05X
- (no location specified)
Apr 22, 2022
Advanced Solid Tumors Trial in Shanghai (HLX07+Gemcitabine+Cisplatin, HLX07+Paclitaxel+Carboplatin, HLX07+mFOLFOX6)
Active, not recruiting
- Advanced Solid Tumors
- HLX07+Gemcitabine+Cisplatin
- +2 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
May 5, 2022
Alcoholic Cirrhosis Trial in Korea, Republic of (Cellgram-LC)
Recruiting
- Alcoholic Cirrhosis
- Cellgram-LC
-
Bucheon, Korea, Republic of
- +10 more
Oct 25, 2021
Patients Treated With Ilaris® for Gouty Arthritis in France
Completed
- Gouty Arthritis
-
Paris, FranceNovartis
Jul 20, 2023
Prostate Cancer Trial in Canada, Lithuania, United States (No intervention)
Completed
- Prostate Cancer
- No intervention
-
Baltimore, Maryland
- +7 more
Mar 7, 2022
Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Spain, United States (Mitapivat, Mitapivat-matching )
Recruiting
- Pediatric Pyruvate Kinase Deficiency
- Pediatric Hemolytic Anemia
- Mitapivat
- Mitapivat-matching placebo
-
Phoenix, Arizona
- +3 more
Aug 8, 2022
End Stage Renal Disease on Dialysis (Diagnosis) Trial in Birmingham (Tunneled dialysis catheter placement.)
Withdrawn
- End Stage Renal Disease on Dialysis (Diagnosis)
- Tunneled dialysis catheter placement.
-
Birmingham, AlabamaUniversity of Akabama at Birmingham
May 6, 2021
Migraine Trial in United States (AXS-07 (MoSEIC meloxicam and rizatriptan), Placebo)
Completed
- Migraine
- AXS-07 (MoSEIC meloxicam and rizatriptan)
- Placebo
-
Birmingham, Alabama
- +40 more
Apr 28, 2021
Health Risk Behaviors, Healthy Lifestyle, Non Communicable Diseases Trial in Antalya (MetaHealth Group, MobileHealth Group)
Not yet recruiting
- Health Risk Behaviors
- +7 more
- MetaHealth Group
- MobileHealth Group
-
Antalya, Konyaaltı, TurkeyAysegul ISLER DALGIC
Apr 15, 2022
Migraine Trial in United States (AXS-07 (MoSEIC meloxicam and rizatriptan), Meloxicam, Rizatriptan)
Completed
- Migraine
- AXS-07 (MoSEIC meloxicam and rizatriptan)
- +3 more
-
Birmingham, Alabama
- +84 more
Apr 22, 2021
Orthodontic Appliance Complication Trial in Baghdad (Insignia™ twin brackets, Maestro® 3D Ortho Studio software (Discovery,
Completed
- Orthodontic Appliance Complication
- Insignia™ twin brackets
- +2 more
-
Baghdad, Iraqcollage of dentistry-Baghdad university
Sep 21, 2022